Skip to main content

Breadcrumb

  1. Home

Risk-Adjusted Deep Sternal Wound Infection

  • Percent of patients aged 18 years and older undergoing isolated CABG for whom mediastinitis or deep sternal wound infection is diagnosed within 30 days postoperatively or at any time during the hospitalization for surgery

    CBE ID
    0130

Risk-Adjusted Stroke/Cerebrovascular Accident

  • Percent of patients aged 18 years and older undergoing isolated CABG who have a postoperative stroke (i.e., any confirmed neurological deficit of abrupt onset caused by a disturbance in blood supply to the brain) that did not resolve within 24 hours

    CBE ID
    0131

Risk-Adjusted Postoperative Renal Failure

  • Percent of patients aged 18 years and older undergoing isolated CABG (without pre-existing renal failure) who develop postoperative renal failure or require dialysis

    CBE ID
    0114

Risk-Adjusted Surgical Re-exploration

  • Percent of patients aged 18 years and older undergoing isolated CABG who require a re-intervention during the current hospitalization for mediastinal bleeding with or without tamponade, graft occlusion, valve dysfunction, or other cardiac reason

    CBE ID
    0115

Beta Blockade at Discharge

  • Percent of patients aged 18 years and older undergoing isolated CABG who were discharged on beta blockers

    CBE ID
    0117

Anti-Lipid Treatment Discharge

  • Percent of patients aged 18 years and older undergoing isolated CABG who were discharged on a lipid lowering statin

    CBE ID
    0118

Risk-Adjusted Operative Mortality for CABG

  • Percent of patients aged 18 years and older undergoing isolated CABG who die, including both 1) all deaths occurring during the hospitalization in which the CABG was performed, even if after 30 days, and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure

    CBE ID
    0119

Risk-Adjusted Operative Mortality for Aortic Valve Replacement (AVR)

  • Percent of patients aged 18 years and older undergoing Aortic Valve Replacement (AVR) who die, including both 1) all deaths occurring during the hospitalization in which the procedure was performed, even if after 30 days, and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure

    CBE ID
    0120

Risk-Adjusted Operative Mortality for Mitral Valve (MV) Replacement

  • Percent of patients aged 18 years and older undergoing MV Replacement who die, including both 1) all deaths occurring during the hospitalization in which the procedure was performed, even if after 30 days, and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure

    CBE ID
    0121